Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#BROMPHERIL ×

Actualizaciones regulatorias

9 sept 2026•1 min de lectura

FDA Approves ANDA089116 for BROMPHERIL Extended-Release Tablet

FDA approved ANDA089116 for BROMPHERIL, an oral extended-release tablet containing 6 mg dexbrompheniramine maleate and 120 mg pseudoephedrine sulfate, submitted by Copley Pharm; product is listed as discontinued.